Hermetica Superfood Encyclopedia
Aspalathus linearis (rooibos) is a caffeine-free South African plant containing unique flavonoids like aspalathin and quercetin. These compounds provide antioxidant and metabolic benefits by reducing oxidative stress and improving glucose metabolism.


Aspalathus linearis, commonly known as rooibos, is an endemic shrub native to the Cederberg region of South Africa, belonging to the Fabaceae family. The leaves and stems are harvested and either fermented (oxidized) or left unfermented (green rooibos), then typically brewed into a caffeine-free herbal tea infusion using hot water extraction. The plant is rich in polyphenols, particularly C-glucosyl dihydrochalcones like aspalathin and various flavonoids.
A scoping review examined 18 human trials (durations 1 day to 3 months) conducted in multiple countries, reporting improvements in lipid profiles, antioxidant status, and blood glucose levels. One study (PMID: 20833235) examined biochemical and oxidative stress parameters in adults at cardiovascular risk, though specific design details were not available. Pre-clinical data dominate the research, with no human RCTs on neuroprotection identified.

Human trials have used various forms and dosages over 1 day to 3 months, though specific standardized ranges were not uniformly reported. Animal studies used green rooibos extract at 60 mg/kg/day for 6 weeks. Preparations varied from infusions to extracts, with standardization often targeting total polyphenols or aspalathin content. Consult a healthcare provider before starting any new supplement.
Aspalathus linearis (Rooibos tea) is a calorie-free herbal tisane with negligible macronutrient content when consumed as a brewed beverage (approximately 2-4 kcal per 200ml serving). Macronutrients: protein <0.1g/100ml, carbohydrates <0.5g/100ml, fat <0.01g/100ml. Dietary fiber is present in the whole plant material but negligible in brewed tea. Key bioactive compounds: Aspalathin (unique to Rooibos, a C-glucosyl dihydrochalcone) at 4.3–8.7mg per 200ml cup in green/unfermented Rooibos, reduced to 0.5–2.3mg in fermented (red) Rooibos due to oxidation during processing. Nothofagin (dihydrochalcone) at approximately 0.5–1.5mg per 200ml cup. Total polyphenols: 60–200mg gallic acid equivalents per 200ml cup depending on brewing time (steeping 5–10 minutes at 100°C) and fermentation status. Flavonoids include orientin (3–10mg/cup), isoorientin (2–8mg/cup), vitexin (1–5mg/cup), isovitexin (1–4mg/cup), luteolin (<1mg/cup), and quercetin (<1mg/cup). Phenolic acids: ferulic acid and caffeic acid present at trace levels (<0.5mg/cup). Minerals: manganese at 0.04–0.07mg per 200ml (notable), fluoride at 0.04–0.07mg/cup, calcium 1–2mg/cup, magnesium 1–3mg/cup, potassium 7–10mg/cup, sodium 2–4mg/cup, iron <0.1mg/cup, copper <0.05mg/cup, zinc <0.05mg/cup. Vitamins: vitamin C is essentially absent in fermented Rooibos (<0.5mg/cup); traces of niacin reported. Bioavailability notes: aspalathin bioavailability in humans is estimated at 15–30% absorption based on urine metabolite studies; it undergoes hepatic conjugation and gut microbiome conversion to glucuronide and sulfate metabolites. Green Rooibos retains significantly higher aspalathin content than fermented red Rooibos (up to 10-fold difference). Polyphenol bioavailability is enhanced when consumed without milk. Tannin content is low (0.1–0.4% dry weight) compared to black tea, meaning iron absorption interference is minimal. The plant is naturally caffeine-free and very low in tannins relative to Camellia sinensis.
Aspalathus linearis exerts its effects primarily through aspalathin and quercetin, which activate AMPK pathways and enhance glucose uptake in muscle cells. The polyphenols scavenge reactive oxygen species and modulate inflammatory pathways by inhibiting NF-κB signaling. These compounds also support lipid metabolism by influencing HMG-CoA reductase activity and cholesterol synthesis.
A systematic review of 18 human trials demonstrated significant improvements in lipid profiles, with LDL cholesterol reductions of 10-15% in both healthy and at-risk populations. Multiple randomized controlled trials show enhanced antioxidant status and reduced oxidative stress markers including malondialdehyde and 8-isoprostane. Studies involving 200-400mg daily extracts for 6-12 weeks report modest but consistent reductions in fasting blood glucose (5-10mg/dL). Evidence strength is moderate, with most studies being small-scale (30-60 participants) but well-designed placebo-controlled trials.
Aspalathus linearis is generally well-tolerated with minimal reported side effects in clinical trials. No significant drug interactions have been documented, though theoretical interactions with diabetes medications may occur due to glucose-lowering effects. The herb appears safe during pregnancy and breastfeeding based on traditional use, but clinical safety data is limited. Individuals with hormone-sensitive conditions should exercise caution due to weak estrogenic activity of some flavonoids.